Preclinical Assessment of Drug-drug interaction of fb-PMT, a novel anti-cancer thyrointegrin αvβ3 antagonist.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and translational science"
DOI: 10.1111/cts.13504
Abstract: The objective of the current study was to identify potential drug-drug interactions (DDIs) with the drug candidate fb-PMT, a novel anti-cancer thyrointegrin αvß3 antagonist. This was accomplished by using several in vitro assays to study… read more here.
Keywords: drug drug; pmt novel; novel anti; drug ... See more keywords